SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹86 Cr | ₹79 Cr | ₹119 Cr | ₹93 Cr | ₹43 Cr |
What is the latest Total Debt ratio of SAKAR HEALTHCARE ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹79 Cr |
| Mar2023 | ₹119 Cr |
| Mar2022 | ₹93 Cr |
| Mar2021 | ₹43 Cr |
How is Total Debt of SAKAR HEALTHCARE Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹86 Cr | 8.85 | |
| Mar2024 | ₹79 Cr | -33.42 | |
| Mar2023 | ₹119 Cr | 28.34 | |
| Mar2022 | ₹93 Cr | 118.00 | |
| Mar2021 | ₹43 Cr | - | |
Compare Total Debt of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,827.8 Cr | 1.4% | 6.5% | 136.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 1.4% |
6.5% |
136.8% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses